In 2015 researchers discovered that the prodrug DHED that selectively delivers 17β-estradiol to the brain for treating estrogen responsive disorder, halted or slowed down the…
The final week of August brought two new FDA approvals for Parkinson's medications. MYOBLOC (rimabotulinumtoxinB) - a botulinum toxin type B, was indicated for the treatment of chronic…